Northern Trust’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.13M Sell
189,249
-48,808
-21% -$1.59M ﹤0.01% 2266
2025
Q4
$7.16M Buy
238,057
+71,063
+43% +$2.01M ﹤0.01% 2260
2025
Q3
$4.38M Buy
166,994
+58,125
+53% +$1.39M ﹤0.01% 2572
2025
Q2
$2.32M Buy
108,869
+31,928
+41% +$720K ﹤0.01% 2901
2025
Q1
$1.64M Buy
76,941
+3,947
+5% +$81K ﹤0.01% 3024
2024
Q4
$1.48M Buy
+72,994
New +$1.51M ﹤0.01% 3183

Other funds holding GRDN

Northern Trust's GRDN Position: Q1 2026 in Review

Northern Trust reduced its Guardian Pharmacy Services (GRDN) stake by 21% in Q1 2026, selling an estimated $1.59M and leaving 189,249 shares worth $7.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2266.

Northern Trust first reported a position in GRDN in Q4 2024 and has held it in 6 quarters since. The position peaked at $7.16M in Q4 2025. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Northern Trust held 189,249 shares of Guardian Pharmacy Services worth $7.13M as of Q1 2026.
  • Northern Trust sold 48,808 Guardian Pharmacy Services shares in Q1 2026, an estimated $1.59M.
  • Guardian Pharmacy Services made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2266 holding.
  • Northern Trust first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 6 quarters since.
  • Northern Trust's Guardian Pharmacy Services position peaked at $7.16M in Q4 2025.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.